<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diet-derived <z:chebi fb="0" ids="17968">butyrate</z:chebi>, a <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase inhibitor (<z:chebi fb="5" ids="53578">HDI</z:chebi>), decreases proliferation and increases <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells via epigenetic changes in gene expression </plain></SENT>
<SENT sid="1" pm="."><plain>Other <z:chebi fb="5" ids="53578">HDIs</z:chebi> such as suberoylanilide <z:chebi fb="0" ids="24650">hydroxamic acid</z:chebi> (SAHA) and <z:chebi fb="0" ids="46024">trichostatin A</z:chebi> (TSA) have similar effects </plain></SENT>
<SENT sid="2" pm="."><plain>This study examined the role of microRNAs (miRNAs) in mediating the chemo-protective effects of <z:chebi fb="5" ids="53578">HDIs</z:chebi>, and explored functions of the oncogenic miR-17-92 cluster </plain></SENT>
<SENT sid="3" pm="."><plain>The dysregulated miRNA expression observed in HT29 and HCT116 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells could be epigenetically altered by <z:chebi fb="0" ids="17968">butyrate</z:chebi>, SAHA and TSA </plain></SENT>
<SENT sid="4" pm="."><plain>These <z:chebi fb="5" ids="53578">HDIs</z:chebi> decreased expression of miR-17-92 cluster miRNAs (P &lt; 0.05), with a corresponding increase in miR-17-92 target genes, including PTEN, BCL2L11, and CDKN1A (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The decrease in miR-17-92 expression may be partly responsible for the anti-proliferative effects of <z:chebi fb="5" ids="53578">HDIs</z:chebi>, with introduction of miR-17-92 cluster miRNA mimics reversing this effect and decreasing levels of PTEN, BCL2L11, and CDKN1A (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The growth effects of <z:chebi fb="5" ids="53578">HDIs</z:chebi> may be mediated by changes in miRNA activity, with down-regulation of the miR-17-92 cluster a plausible mechanism to explain some of the chemo-protective effects of <z:chebi fb="5" ids="53578">HDIs</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Of the miR-17-92 cluster miRNAs, miR-19a and miR-19b were primarily responsible for promoting proliferation, while miR-18a acted in opposition to other cluster members to decrease growth </plain></SENT>
<SENT sid="8" pm="."><plain>NEDD9 and CDK19 were identified as novel miR-18a targets and were shown to be pro-proliferative genes, with <z:chebi fb="40" ids="33697">RNA</z:chebi> interference of their transcripts decreasing proliferation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="9" pm="."><plain>This is the first study to identify competing roles for miR-17-92 cluster members, in the context of <z:chebi fb="5" ids="53578">HDI</z:chebi>-induced changes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells. © 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>